Vincerx Pharma, Inc. Warrant
VINCW
VINCW was delisted on the 5th of May, 2021.
0 hedge funds and large institutions have $0 invested in Vincerx Pharma, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.
100% less funds holding
Funds holding: 17 → 0 (-17)
100% less capital invested
Capital invested by funds: $20.2M → $0 (-$20.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 17
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.1M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.9M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.1M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$2.02M |
| 5 |
RI
RTW Investments
New York
|
-$2.02M |
VINCW Hedge Fund Activity: Q2 2021 in Review
0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Warrant (VINCW) for Q2 2021, worth a combined $0 — down 100% from $20.2M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of VINCW and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Tang Capital Management, exiting entirely with an estimated $4.1M sold.
- 0 institutional investors held Vincerx Pharma, Inc. Warrant (VINCW) as of Q2 2021, down from 17 in Q1 2021.
- Funds reported $0 of Vincerx Pharma, Inc. Warrant stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Vincerx Pharma, Inc. Warrant positions in Q2 2021 and 17 closed out, a net change of -17 holders.
- The largest Vincerx Pharma, Inc. Warrant seller in Q2 2021 was Tang Capital Management, an estimated $4.1M sold.
Based on aggregated 13F filings for Q2 2021.